Research indicates that YBX1 can promote the stability of multiple oncogenic transcripts in breast cancer cells by binding to the 3′UTR region of mRNA.[35] Analysis using the Mapping Binding Sites of RNA Binding Proteins database identified several potential binding sites for YBX1 in the 3′UTR region of CDK1 (Figure S4I, Supporting Information). Here, CDK1 is linked to breast cancer.